throbber
Biochimica et Biophysica Acta. 1014 (1989) 207-209
`Elsevier
`
`BBAMCR 10245
`
`BBAReport
`
`207
`
`Nicardipine as a Ca2+ channel blocker in single barnacle
`muscle fibers
`
`Huiwen Xie and E. Edward Bittar
`Department of Physiology, University of Wisconsin, Madison, WI (U.S.A.)
`
`(Received 10 May 1989)
`
`Key words: Nicardipine; Verapamil; Calcium ion channel; (Barnacle muscle fiber)
`
`A study has been made of the efficacy of nicardipine as a Ca2+ channel blocker by determining the magnitude of its
`effect on the stimulatory response of the ouabain-insensitive Na + efflux in single barnacle muscle fibers to 100 mM
`external K +, The results show ~hat nicardlpine (at pH 6.5) is a potent inhibitor, the minimal effective concentration
`being approx. 10 _., M and the IC!IO about 5 •10 _, M. Nicardipine, however, is not as potent as verapamil (at pH 6.5)
`on an equimolar basis. This is explained by assuming that the number of dihydropyridine receptors in the t-tubule
`membnmes of barnacle fibers is not high or that verapamil is able to block the sarcoplasmic retiwlum Ca2+ release
`channel in addition to the voltage-dependent ea2+ channels.
`
`Calcium channel blockers fall into two main classes:
`the dihydropyridine (DHP) and the non-DHP class. An
`example of the former is nifedipine or nicardipine, and
`of the latter verapamil or diltiazem. These drugs are
`known to block L-type, and not the T-orN-type Ca2+
`channel by binding to the a 1-subunit of the channel
`protein, a rather unique polypeptide of Mr 170 000,
`which has e sequence and membrane topology similar
`to that of the voltage-dependent Na + channel [1-5).
`Since the t-tubule membrane of skeletal muscle is the
`richest source of DHP receptors [6,7], skeletal muscle
`has proven to be a remarkably useful experimental
`preparation for various studies of the Ca 2+ channel,
`including its identification and purification.
`The work of Hagiwara and coworkers, e.g., Hagiwara
`[8] has shown that the action potential in barnacle fibers
`is Ca2+. rather than Na+-dependent, and that the volt(cid:173)
`age-dependent Ca2 + channels can be readily activated
`by depolarizing the fiber membrane, e.g., with high
`external K + (K; ), and inactivated by various agents,
`including verapamil. Depolarization of the barnacle
`muscle fibers membrane with high K; is also known to
`stimulate the ouabain-insensitive Na +efflux temporari(cid:173)
`ly by a mechanism which is readily stopped by prior
`external application of verapamil, injection of EGTA or
`
`Abbreviations: DHP, dihydropyridine; ASW, artificial sea water.
`
`Correspondence: E.E. Biuar, Department of Physiology, University of
`Wisconsin, 1300 University Avenue, Madison, WI 53'106, U.S.A.
`
`removal of external calcium [9]. These observations, in
`combination with other lines of evidence, have led to
`the conclusion that the observed rise in Na + efflux is
`due to a fall in myoplasmic pCa, resulting from the
`activation of volt&ge-dependent Ca2 + channels [10].
`Since verapamil has thus far been used as the standard
`Ca2 + channel blocker in this laboratory, it seemed a
`matter of special interest to examine the DHP class of
`drugs, and the derivative chosen in this instance for
`such testing is nicardipine. This communication de(cid:173)
`scribes experiments carried out using nicardipine with
`the main aim of determining whether it acts as a blocker
`in barnacle muscle fibers and whether it is as effective
`as verapamil.
`Specimens of the barnacle, Balanus nubilus were the
`source of single muscle fibers. The methods and proce(cid:173)
`dures used were essentially the same as those described
`elsewhere [10]. The artificial sea water (ASW) used as
`bathing solution contained 10 mM K+. ASW containing
`100 mM K+ was prepared by lowering NaCl in osmoti(cid:173)
`cally equivalent amounts. All bathing solutions used
`contained 10 mM imidazole as buffer in lieu of HC03,
`with the pH adjusted to 6.5. This was necessary because
`nicardipine has the following solubility profile: in only
`water (at 25°C), 8 ·10- 6 M at pH 7.4 (using 0.05 M
`phosphate as buffer) and approx. 10- 2 M at pH 4.6.
`Nicardipine in solution is known to be degraded by
`light but only about 2% of it undergoes breakdown over
`a 24 h period at a temperature of 30 ° C. (Information
`from Syntex Research, Palo Alto, CA.) Hence the ex(cid:173)
`periments described here were not carried out in the
`
`0167-4889/89/$03.50 © 1989 Elsevier Science Publishers B.V. (Biomedical Division)
`
`CRTXCAR0007011
`
`EKR Therapeutics, LLC Exhibit 2019 Page 1
`
`

`

`208
`
`Fig. 1. Upper panel: the response or the ouabain-insensitive Na +
`ernux following a sudden lO.fold increase inK; in the presence of
`10-4 M nicardipine (rate constant for 22 Na efflux plot). Lower panel:
`the response of the ouabain-insensitive Na + efRux to a sudden 10-fold
`increase in Kt. Note that the time-frame of such control experiments
`is short, since the main object is to determine the magnitude of the
`stimulatory response. The rule is that the ouabain-insensitive Na+
`efflux returns to its original baseline [9].
`
`dark. All experiments were performed at room tempera(cid:173)
`ture 23 ± 1 o C. Changes in the ouabain-insensitive Na +
`efflux were estimated on the basis of the rate constant
`for 22Na efflux plots, and expressed as a percentage
`change (mean ± S.E. of mean) of the efflux. Ouabain,
`imidazole and Hepes were purchased from Sigma
`Chemical Company, St. Louis, MO. Nicardipine HCl
`was a gift from Syntex Research, Palo Alto, CA. ( ± )(cid:173)
`Verapamil HCl was obtained from Knoll Pharmaceuti(cid:173)
`cal Company, Whippany, NJ.
`In the first group of experiments, fibers suspended in
`10 mM imidazole/ ASW (pH 6.5) were treated with
`to-• M ouabain and 10-4 M nicardipine before de(cid:173)
`polarization by suddenly raising K; 10-fold (i.e., from
`10 to 100 mM). Companion controls were not exposed
`to nicardipine. The results of these experiments show
`that nicardipine causes a marked reduction in the mag(cid:173)
`nitude of the stimulatory response of the ouabain-insen(cid:173)
`sitive Na + efflux to high K!. A representative experi(cid:173)
`ment is presented in Fig. 1, where it can be seen that
`whereas external application of 10-4 M nicardipine is
`without effect on the resting ouabain-insensitive N a+
`efflux, it drastically reduces the size of the response to
`100 mM K~ (upper panel). Notice too that the residual
`response fails to decay completely, a situation that
`differs from that in the companion control fiber (lower
`panel); that is, the response of fibers exposed to high
`K + is rapid both in its full development and decay, with
`a return of the ouabain-insensitive Na + efflux to its
`original baseline level (e.g., Ref. 9). The magnitude of
`
`O
`
`5
`6
`7
`CD
`I'
`-LOG MOLAR NICARDIPINE CONCENTRATION
`Fig. 2. Concentration-response curve for the inhibitory action of
`nicardipine on the response of the ouabain-insensitive Na + efflux to
`100 mM K;. Vertical bars indicate±S.E.M. Each plotted point is the
`mean value of three determinations. All fibers were isolated from the
`same barnacle specimen.
`
`4
`
`the response in the presence of 10- 4 M nicardipine
`averages ·162 ± 24$ ( n == 19), as compared with 550 ±
`54% (n = 10) in controls (P < 0.001). To investigate this
`effect more closely, a concentration-response curve was
`determined. Shown in Fig. 2 is that the minimal effec(cid:173)
`tive concentration of nicardipine is roughly 10-7 M and
`that the concentration required to reduce the size of the
`response to 100 mM K; by 50% (i.e., the IC50 ) is
`4.5 ·10- 6 M (log scale). A threshold concentration of
`10-7 M is an interesting finding, particularly since it
`approaches the plasma concentration of nicardipine
`measured in healthy human volunteers receiving ther(cid:173)
`apeutic doses of nicardipine orally [11 ].
`Since this IC50 is about 10-times that for verapamil
`[9], and since the pKa of nicardipine and verapamil is
`7.2 and 8.5, respectively, it seemed important to com(cid:173)
`pare their efficacy using ASW at a low pH, e.g., 6.5. As
`
`ri0"4 M·VERAPAMIL~
`
`. - - - - IOOmM-K+
`
`lr---- 10"4 M·OUABAIN - - - - - . . ,1
`1
`..... ~ !
`..... .
`
`,_.161+1~~··~·~-~IMMI~~~ . . . . ~ ... I-1
`
`- -
`10"4 M·OUABAIN - - - - - .
`r 10"4 M·NICARDIPINEJ.
`1.
`+
`~ !
`1 roomM·K ~
`
`1
`
`Fig. 3. Upper panel: almost complete abolition of the response of the
`
`ouabain-insensitive Na+ efflux to 100 mM K: by to- 4 M verapamil.
`Lower panel: the response of the ouabain-insensitive Na + efflux to
`100 mM K: in the presence of 10-4 M nicardipine. Note that
`in both instances, verapamil and nicardipine were omitted at
`t=140min.
`
`CRTXCAR0007012
`
`EKR Therapeutics, LLC Exhibit 2019 Page 2
`
`

`

`illustrated in Fig. 3, 10- 4 M verapamil almost com(cid:173)
`pletely abolishes the response of the ouabain-insensitive
`Na+ efflux to 100 mM K; (a residual response which
`averages 64 ± 9%, n = 8), whereas 10-4 M nicardipine
`is less effective as a blocker (a residual response which
`averages 162 ± 24%, n = 19). The difference in the two
`sizes is significant, P being < 0.01.
`The message which emerges is that nicardipine is less
`effective than verapamil as a Ca2 + channel blocker.
`However, this conclusion is based only on experiments
`that involve the monitoring of the ouabain-insensitive
`Na + efflux before and after suddenly raising the exter(cid:173)
`nal K. + concentration. The reason why nicardipine is at
`least not equipotent is unclear, particularly since it is
`supposed to bind to the Ca2+ channel protein both
`stereospecifically and with high affinity. pH is not likely
`to be a major factor (Triggle, D., private cori:ununica(cid:173)
`tion); for example, [3H]nitrendipine binding tot-tubule
`membranes increases as the pH is increased from 4 to
`6.5, but the increase then stops [12]. [3H]Verapamil
`binding also increases as pH is increased from 5 to 7.5,
`and then stops increasing [13]. In the former case, the
`titration plot indicates the existence of an ionizable
`group with a pK of 6.5, while in the latter case, the pK
`of the ionizable group is about 5.4. Although this value
`approaches the pK of an ionizable group found in the
`Ca2+ channel of barnacle fibers [14], there is little or no
`change in the inward Ca2 + current in the pH range of
`6-8 [15].
`Several explanations for the results obtained with
`nicardipine can be given. One is simply that the drug
`does not completely block the voltage-dependent Ca2 +
`channels present in barnacle fibers because dihydro(cid:173)
`pyridine receptors are not in abundance. Another ex(cid:173)
`planation which comes from the recent work of Valdivia
`and Coronado [16] is that verapamil, but not the 1,4-di(cid:173)
`hydropyridines, is able to block the sarcoplasmic re(cid:173)
`ticulum (SR) Ca2+ release channel in skeletal muscle. If
`this be true in barnacle fibers, one would then expect
`the residual response to 100 mM K; in the presence of
`
`209
`
`nicardipine to be due to a fall in myoplasmic pCa
`resulting from the inability of nicardipine to clamp the
`SR Ca 2 + release channel. Whether the residual response
`can be abolished by the sudden removal of external
`Ca2 + or injection of EGTA remains to be seen.
`
`Special thanks are due to Dr. R. Simmons of Syntex
`Research Inc., Palo Alto, CA for a supply of nicardipine
`HCI.
`
`References
`
`1 Venter, J.C. and Triggle, D. (eds.) (1987) Structure and Physiolugy
`of the Slow Inward Calcium Channel, Alan R. Liss, New York.
`2 Borsotto, M., Barhanin, J., Fosset, M. and Lazdunski, M. (1985) J.
`Bioi. Chern. 260, 14255.
`3 Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi,
`H., Kagawa, K., Kojima, M., Matsuo, H., Hirose, T. and Numa, S.
`(1987) Nature 328, 313-318.
`4 Ellis, S.D., Williams, M.E., Ways, N.R., Brenner, R., Sharp, A.H.,
`Leung, A.T., Campbell, K.P., McKenna, E., Koch, W.J., Hui, A.,
`Schwartz, A. and Harpold, M.M. (1988) Science 241, 1661-1664.
`5 Catterall, W.A. (1988) Science 242, 50-61.
`6 Glossmann, H., Ferry, D.R. and Boschek, C.B. (1988) Naunyn·
`Schmiedeberg's Arch. Pharmacol. 323, 1-11.
`7 Curtis, B.M. and Catterall, W.A.
`(1984) Biochemistry 23,
`2113-2118.
`8 Hagiwara, S. (1983) Membrane Potential-Dependent Ion Channels
`in Cell Membrane, Raven Press, New York.
`9 Mason-Sharp, D. and Bittar. E.E. (1981) J. Membr. Bioi. 58,
`213-226.
`10 Bittar, E.E. (1983) Progr. Neurobiol. 20, 1-54.
`11 Dow, R.J. and Graham, D.J.M. (1986) Dr. J. Clin. Pharmacal. 22,
`1955-2025.
`.
`12 Fosset, M., Jainovich, E., Delpont, E. and Lazdunski, M. (1983) J.
`Bioi. Chern. 258, 6086-6092.
`13 Galizzi, J.-P., Fosset, M. and Lazdunski, M. (1984) Eur. J. Bio·
`chem. 144, 211-215.
`14 Murayama, K. and Lakshminarayanaiah, N. (1977) J. Membr.
`Bioi. 35, 257-283.
`15 Lakshminarayanaiah, N. (1981) New Perspectives on Calcium
`Antagonists, (G.B. Weiss, ed.), pp. 19-33, American. Physiological
`Society, Bethesda, MD.
`16 Valdivia, H.H. and Coronado, R. (loJ89) Biophys. J. 55, 207a.
`
`CRTXCAR0007013
`
`EKR Therapeutics, LLC Exhibit 2019 Page 3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket